R. Wolters

发表

Comparing the outcome between multicentric and multifocal breast cancer: what is the impact on survival, and is there a role for guideline-adherent adjuvant therapy? A retrospective multicenter cohort study of 8,935 patients

I. Novopashenny, R. Kreienberg, F. Ebner, 2013, Breast Cancer Research and Treatment.

Guidelines are advantageous, though not essential for improved survival among breast cancer patients

Maria Blettner, Igor Novopashenny, Lukas Schwentner, 2015, Breast Cancer Research and Treatment.

Do T1a breast cancers profit from adjuvant systemic therapy? A multicenter retrospective cohort study of 325 T1a-patients

R. Kreienberg, F. Ebner, W. Janni, 2016, Archives of Gynecology and Obstetrics.

The impact of adjuvant radiotherapy on the survival of primary breast cancer patients: a retrospective multicenter cohort study of 8935 subjects.

R. Kreienberg, T. Wiegel, W. Janni, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Endocrine therapy in obese patients with primary breast cancer: another piece of evidence in an unfinished puzzle

R. Kreienberg, A. Regierer, L. Schwentner, 2012, Breast Cancer Research and Treatment.

There Is a Significant Association between 100% Treatment Adherence and Higher Recurrence-Free and Overall Survival in Early-Onset Patients with Breast Cancer – Conclusions from an Empty Subset of Patients Do Not Change This Statement

R. Kreienberg, D. Varga, R. Wolters, 2011, Oncology.

Triple-negative breast cancer: the impact of guideline-adherent adjuvant treatment on survival—a retrospective multi-centre cohort study

K. Koretz, R. Kreienberg, L. Schwentner, 2012, Breast Cancer Research and Treatment.

An internally and externally validated prognostic score for metastatic breast cancer: analysis of 2269 patients.

H. Samonigg, C. Köhne, K. Possinger, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

High estrogen receptor expression in early breast cancer: chemotherapy needed to improve RFS?

R. Kreienberg, K. Possinger, A. Regierer, 2011, Breast Cancer Research and Treatment.

Survival of patients with bilateral versus unilateral breast cancer and impact of guideline adherent adjuvant treatment: a multi-centre cohort study of 5292 patients.

R. Kreienberg, L. Schwentner, A. Wöckel, 2012, Breast.

Does Guideline-Adherent Therapy Improve the Outcome for Early-Onset Breast Cancer Patients?

R. Kreienberg, D. Varga, Rolf Kreienberg, 2010, Oncology.

Clinical Criteria Replenish High-Sensitive Troponin and Inflammatory Markers in the Stratification of Patients with Suspected Acute Coronary Syndrome

M. Hersberger, A. von Eckardstein, T. Lüscher, 2014, PloS one.

M. Hersberger, A. von Eckardstein, T. Lüscher, 2015, Cardiology.

Metastatic breast cancer: are we treating the same patients as in the past?

C. Köhne, K. Possinger, A. Regierer, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Effects of guideline adherence in primary breast cancer--a 5-year multi-center cohort study of 3976 patients.

R. Kreienberg, D. Varga, A. Wöckel, 2010, Breast.

The impact of adjuvant radiotherapy on the survival of primary breast cancer patients: a retrospective multicenter cohort study of 8935 subjects.

R. Kreienberg, T. Wiegel, W. Janni, 2014 .

BRENDA-Score, a Highly Significant, Internally and Externally Validated Prognostic Marker for Metastatic Recurrence: Analysis of 10,449 Primary Breast Cancer Patients

M. Blettner, R. Kreienberg, F. Ebner, 2021, Cancers.

[Effects of guideline-compliant therapy on the survival of primary breast cancer patients with: results of a retrospective cohort study].

R. Kreienberg, A. Wöckel, R. Wolters, 2011, Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen.

Impact of Guideline Conformity on Breast Cancer Therapy: Results of a 13-Year Retrospective Cohort Study

R. Kreienberg, D. Varga, A. Wöckel, 2010, Oncology Research and Treatment.

Implications for surveillance for breast cancer patients based on the internally and externally validated BRENDA-metastatic recurrence score

F. Ebner, W. Janni, A. Wöckel, 2023, Breast Cancer Research and Treatment.

An internally and externally validated prognostic score for metastatic breast cancer: analysis of 2269 patients.

H. Samonigg, C. Köhne, K. Possinger, 2014 .

Supporting clinical guidelines using DL-temporal reasoning

Dieter Hutter, Serge Autexier, Mohamed Bawadekji, 2013, 2013 10th International Conference and Expo on Emerging Technologies for a Smarter World (CEWIT).

Does Guideline-Adherent Therapy Improve the Outcome for Early-Onset Breast Cancer Patients?

R. Kreienberg, D. Varga, R. Wolters, 2010, Oncology.

A comparison of international breast cancer guidelines - do the national guidelines differ in treatment recommendations?

R. Kreienberg, K. Possinger, A. Regierer, 2012, European journal of cancer.